Systemic lupus erythematosus (SLE) is a life-long systemic autoimmune disease with a large variability in its clinical course. The onset of SLE during childhood and adolescence represents 10 to 20% of all SLE cases \[1\] and is associated with a more severe disease course compared to adult SLE. Due to earlier diagnosis as well as significant advances in the management of childhood-onset SLE (C-SLE), mortality rates have greatly decreased, with an estimated 5- to 10-year survival rate of over 85% \[2\].As a consequence, there has been a great increase in long-term co-morbidities, particularly cardiovascular disease (CVD), which is currently considered a major cause of long-term mortality in C-SLE patients \[3\].
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Cardiorespiratory exercise test: Peak VO2 (mL/min
Timeframe: base line and 12 weeks
Cardiorespiratory exercise test:Peak W (w) (working rate) (Watts)
Timeframe: base line and after 12 weeks
Cardiorespiratory exercise test:Chronotropic reserve (CR) %
Timeframe: base line and after 12 weeks